AshishM.KamatMDMBBS, FACS

PubMed

• Frequency and Nature of Genomic Alterations in ERBB2-Altered Urothelial Bladder Cancer.
  Jacob B Leary, Thomas Enright, Dimitra Rafailia Bakaloudi, Alina Basnet, Gennady Bratslavsky, Joseph Jacob, Philippe E Spiess, Roger Li, Andrea Necchi, Ashish M Kamat,...> ;Targeted Oncology. 2024 Apr 3
• 'Case of the Month' from The University of Texas MD Anderson Cancer Center, Houston, Texas, USA: ependymoma of the urinary bladder.
  Tan, W., de Groot, J., Myers, A., Westney, O., Kamat, A.> ;BJU International. 2024 Feb 20
• Influence of lamina propria invasion extension on T1 high-grade non-muscle-invasive bladder cancer in patients undergoing BCG or radical cystectomy.
  Contieri, R., Tan, W., Hensley, P., Martini, A., Nogueras-Gonzalez, G., Grajales, V., Bree, K., Myers, A., Navai, N., Dinney, C., Guo, C., Kamat, A.> ;BJU International. 2024 Feb 19
• Toward standardization in bladder cancer clinical trials: Guidance from the SITC-IBCG expert panel.
  Myers, A., Kilbert, A., Kamat, A., Galsky, M.> ;Journal for Immunotherapy of Cancer. 2024 Feb 2
• Standardization of the evaluation and surveillance of patients with BCG unresponsive high grade non-muscle invasive bladder cancer clinical trials.
  Lee, B., Smith, A., Lotan, Y., Agarwal, P., Black, P., Dickstein, R., Kamat, A., Narayan, V., Porten, S., Psutka, S., Svatek, R., Williams, S., Woldu, S.> ;Urologic Oncology. 2024 Feb 1
• Association of Age with Non-muscle-invasive Bladder Cancer: Unearthing a Biological Basis for Epidemiological Disparities?
  Lobo, N., Duan, Z., Tan, W., Contieri, R., Lindskrog, S., Dyrskjøt, L., Zhao, H., Grajales, V., Giordano, S., Williams, S., Bree, K., Kamat, A., Sood, A.> ;European Urology Oncology. 2024 Jan 31
• Characterizing the Genomic Landscape of the Micropapillary Subtype of Urothelial Carcinoma of the Bladder Harboring Activating Extracellular Mutations of ERBB2.
  Jessica M Posada, Evgeny Yakirevich, Ashish M Kamat, Akshay Sood, Joseph M Jacob, Gennady Bratslavsky, Petros Grivas, Philippe E Spiess, Roger Li, Andrea Necchi, Antho...> ;Modern Pathology. 2024 Mar 1
• Open vs Robotic Cystectomy: Case Closed?
  Bochner, B., Kamat, A., Bivalacqua, T.> ;The Journal of Urology. 2024 Mar 1
• Interruptions in bladder cancer care during the COVID-19 public health emergency.
  John L Gore, Kristin Follmer, Jason Reynolds, Michael Nash, Christopher B Anderson, James W F Catto, Karim Chamie, Siamak Daneshmand, Rian Dickstein, Tullika Garg, Sco...> ;Urologic Oncology. 2024 Apr 1
• 1 citations
  Contemporary Role of Lymph Node Dissection in Genitourinary Cancers: Where Are We in 2023?
  Alberto Briganti, Bradley Leibovich, Seth P Lerner, Marco Moschini, Morgan Rouprêt, Shahrokh F Shariat, Philippe E Spiess, Arnulf Stenzl, Samir S Taneja, Karim A Touij...> ;European Urology Oncology. 2023 Nov 16
• Long-Term Oncological Outcomes in Patients Diagnosed With Nonmetastatic Plasmacytoid Variant of Bladder Cancer: A 20-Year University of Texas MD Anderson Cancer Center...
  Jan K Rudzinski, Craig V Labbate, Patrick J Hensley, Kelly K Bree, Charles C Guo, Omar Alhalabi, Matthew T Campbell, Arlene O Siefker-Radtke, Neema Navai, Colin P N Di...> ;The Journal of Urology. 2024 Feb 1
• The 2023 European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: A Critical Appraisal.
  Patrick J Hensley, Ananya Choudhury, Ali Raza Khaki, Petros Grivas, Ashish M Kamat> ;European Urology. 2024 Jan 1
• Comparative Effectiveness Analysis of Treatment Strategies for Surgically Resectable Neuroendocrine Carcinoma of the Urinary Tract.
  Omar Alhalabi, Nathaniel Wilson, Lianchun Xiao, Yiyun Lin, Jaanki Khandelwal, Mohammad Jad Moussa, Pavlos Msaouel, Neema Navai, Jianjun Gao, Ashish M Kamat, Patrick Pi...> ;European Urology Oncology. 2023 Dec 1
• A Territory-wide Study Investigating the Dose and Efficacy of Different Bacillus Calmette-Guérin Strains in Patients with Intermediate- and High-risk Non-muscle-invasi...
  Kang Liu, Hongda Zhao, Xuan Chen, Rossella Nicoletti, Nikhil Vasdev, Peter Ka-Fung Chiu, Chi-Fai Ng, Tatsushi Kawada, Ekaterina Laukhtina, Keiichiro Mori, Takafumi Yan...> ;European Urology Oncology. 2023 Oct 10
• Reply to Francesco Montorsi, Giuseppe Rosiello, and Giorgio Gandaglia's Letter to the Editor re: Roberto Contieri, Patrick J. Hensley, Wei Shen Tan, et al. Oncological...
  Roberto Contieri, Patrick J Hensley, Ashish M Kamat> ;European Urology Oncology. 2024 Apr 1
• 2 citations
  Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Society for Immunotherapy of Cancer and the International Bladder Canc...
  Ashish M Kamat, Andrea B Apolo, Marek Babjuk, Trinity J Bivalacqua, Peter C Black, Roger Buckley, Matthew T Campbell, Eva Compérat, Jason A Efstathiou, Petros Grivas, ...> ;Journal of Clinical Oncology. 2023 Dec 10
• Reply by Authors.
  Wei Shen Tan, Roberto Contieri, Nicolò Maria Buffi, Giovanni Lughezzani, Valentina Grajales, Mark Soloway, Paolo Casale, Rodolfo Hurle, Ashish M Kamat> ;The Journal of Urology. 2023 Nov 1
• A Plea for the Use of Video-recorded Cystoscopy for Blinded Independent Central Review of Tumor Response in Open-label Non-muscle invasive Bladder Cancer Trials.
  Giuseppe Basile, Benjamin Pradere, Joaquim Bellmunt, Morgan Rouprêt, Ashish M Kamat, Thomas Seisen> ;European Urology Oncology. 2023 Oct 1
• 4 citations
  Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early...
  Roberto Contieri, Patrick J Hensley, Wei Shen Tan, Valentina Grajales, Kelly Bree, Graciela M Nogueras-Gonzalez, Byron H Lee, Neema Navai, Colin P Dinney, Ashish M Kamat> ;European Urology Oncology. 2023 Dec 1
• International Bladder Cancer Group Intermediate-risk Nonmuscle-invasive Bladder Cancer Scoring System Predicts Outcomes of Patients on Active Surveillance.
  Wei Shen Tan, Roberto Contieri, Nicolò Maria Buffi, Giovanni Lughezzani, Valentina Grajales, Mark Soloway, Paolo Casale, Rodolfo Hurle, Ashish M Kamat> ;The Journal of Urology. 2023 Nov 1
• 4 citations
  Sequential Intravesical Gemcitabine and Docetaxel is an Alternative to Bacillus Calmette-Guérin for the Treatment of Intermediate-risk Non-muscle-invasive Bladder Cancer.
  Wei Shen Tan, Ian M McElree, Facundo Davaro, Ryan L Steinberg, Kelly Bree, Neema Navai, Colin P Dinney, Michael A O'Donnell, Roger Li, Ashish M Kamat, Vignesh T Packiam> ;European Urology Oncology. 2023 Oct 1
• 4 citations
  Impact of age >70 years on oncological outcomes in patients with non-muscle-invasive bladder cancer treated with Bacillus Calmette-Guérin.
  Roberto Contieri, Valentina Grajales, Wei Shen Tan, Alberto Martini, Patrick Hensley, Kelly Bree, Niyati Lobo, Graciela M Nogueras-Gonzalez, Charles C Guo, Neema Navai...> ;BJU International. 2024 Jan 1
• 3 citations
  Bladder-sparing Treatment in Patients with Bacillus Calmette-Guerin-unresponsive Non-muscle-invasive Bladder Cancer: An Analysis of Long-term Survival Outcomes.
  Wei Shen Tan, Valentina Grajales, Roberto Contieri, Patrick Hensley, Kelly Bree, Pavlos Msaouel, Charles C Guo, Graciela M Nogueras-Gonzalez, Neema Navai, Colin P Dinn...> ;European Urology Open Science. 2023 Jul 1
• 3 citations
  International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 2: Grading of Mixed Grade, Invasive Urothe...
  Gladell P Paner, Ashish Kamat, Hemamali Samaratunga, Murali Varma, Lukas Bubendorf, Theodorus H van der Kwast, Liang Cheng, , George J Netto> ;The American Journal of Surgical Pathology. 2024 Jan 1
• 1 citations
  Clinical trial design for non-muscle-invasive bladder cancer.
  Wei Shen Tan, Emma Hall, Ashish M Kamat, John D Kelly> ;Nature Reviews. Urology. 2023 Oct 1
• Join now to see all

Journal Articles

• Seminars Article New Horizons in Bladder Cancer Research  
  Stephen B Williams, Ashish M Kamat, ScienceDirect
• Utility of Bladder-Sparing Therapy vs Radical Cystectomy for Muscle-Invasive Bladder Cancer—Reply  
  Ashish M Kamat, Stephen B Williams, JAMA
• Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018  
  Ashish M Kamat, Yair Lotan, European Urology
• Comparing Survival Outcomes and Costs Associated with Radical Cystectomy and Trimodal Therapy for Older Adults with Muscle-Invasive Bladder Cancer  
  Jacques G Baillargeon, Douglas S Tyler, Stephen B Williams, Anthony J Senagore, Todd A Swanson, Ashish M Kamat, Eduardo Orihuela, JAMA
• Join now to see all

Lectures

• Bacillus Calmette-Guerin (BCG) with or without pembrolizumab (pembro) for high-risk (HR) nonmuscle invasive bladder cancer (NMIBC) that is persistent or recurrent foll... 
  2019 ASCO Annual Meeting - 6/1/2019